Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Hypertension was the most common (37, 31.4%) comorbid condition followed by kidney disease (23, 19.5%) (Fig. 1).The Clinical characteristics and medication use of hospitalized heart failure patients at MRRH, Southwestern Uganda from November 2021 to January 2022VariablesCategoriesN (%)Duration of the HFNew56 (47.5)Known59 (52.5)Previous hospital admission78 (66.1)Length of hospital stay (days)Median (IQR): 8 (6 to 10)≤527 (22.9)6 to 1059 (50)≥1132 (27.1)Comorbidity93 (78.8)Number of comorbidities (N = 93)One (1)56 (60.2)Two (2) and above37 (39.8)Counseling on medication use107 (90.7)OTC use within the past 4 weeks42 (35.6)Herbal use within the past 4 weeks52 (44.1)Poly-pharmacy75 (63.5)Significant drug-drug interaction79 (66.9)Treatment affordability18 (15.3)*Others: Alcoholic liver disease, Hypothyroidism, Thyrotoxicosis, DVT Pharyngitis, ILD Cholecystitis, PUD Cellulitis, Vitamin D deficiencyCommon comorbid conditions among hospitalized heart failure patients at MRRH, Southwestern Uganda from November 2021 to January 2022

Source: Clinical and medication use characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Observational study.

Observational study

Observes exposures and outcomes without assigning the exposure; the subtype is not established here.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A prospective observational study was conducted among hospitalized HF patients from November 2021 to January 2022.

Source: Abstract.

An average of 30 Heart failure patients per month were admitted to the medical inpatient ward, whereas an average of 7 HF patients were admitted to the pediatric ward.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda

Observational study · BMC Cardiovascular Disorders · 2022

Original publication title

Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda

Efrata Ashuro Shegena; Konjit Abebe Nigussie; Robert Tamukong; Boniface Amanee Elias Lumori; Tadele Mekuriya Yadesa

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

More than half of the hospitalized HF patients experienced at least one ADR during their hospital stay. The use of herbal medicines, poly-pharmacy, and drug-drug interaction were associated with a high risk of ARDs whereas the age group 19 to 59 years was less likely to experience ADRs.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Adverse drug reaction (ADR) of medications remains an obstacle to achieving optimal disease outcomes. This study aimed to assess the prevalence and associated factors of ADR among Heart failure (HF) patients hospitalized at Mbarara Regional and Referral Hospital.

Source: Background

Abstract: What methods does the paper describe?

A prospective observational study was conducted among hospitalized HF patients from November 2021 to January 2022. Univariate and multivariate logistic regression was employed to determine factors associated with the ADR.

Source: Method

Abstract: Result

Overall, 118 HF patients were included in the study with a median age of 43 years. A total of 164 ADRs were identified during the follow-up period of 1011 days. The incidence of new ADRs was 106 ADRs/1000 person-days. The prevalence of ADR was 59.3%. Of the 164 ADRs, 118(71.9%) were probable. The gastrointestinal system was the most frequently (27.5%) affected system. Over half (86, 52.4%) of the ADRs were mild and 96(58.5%) were preventable. Age group 19 to 59(AOR 0.15[0.03 to 0.35] at 95%CI, p = 0.013), herbal use (AOR 3.07[1.01 to 9.32] at 95%CI, p = 0.048), poly-pharmacy (AOR 8.7[2.4 to 15.77] at 95%CI, p < 0.001) and drug-drug interaction (AOR 6.06[2.79 to 12.5] at 95%CI, p = 0.004) were significantly associated with ADRs among HF patients.

Source: Result

Abstract: Conclusion

More than half of the hospitalized HF patients experienced at least one ADR during their hospital stay. The use of herbal medicines, poly-pharmacy, and drug-drug interaction were associated with a high risk of ARDs whereas the age group 19 to 59 years was less likely to experience ADRs.

Source: Conclusion
Authors’ abstract

Background

Adverse drug reaction (ADR) of medications remains an obstacle to achieving optimal disease outcomes. This study aimed to assess the prevalence and associated factors of ADR among Heart failure (HF) patients hospitalized at Mbarara Regional and Referral Hospital.

Method

A prospective observational study was conducted among hospitalized HF patients from November 2021 to January 2022. Univariate and multivariate logistic regression was employed to determine factors associated with the ADR.

Result

Overall, 118 HF patients were included in the study with a median age of 43 years. A total of 164 ADRs were identified during the follow-up period of 1011 days. The incidence of new ADRs was 106 ADRs/1000 person-days. The prevalence of ADR was 59.3%. Of the 164 ADRs, 118(71.9%) were probable. The gastrointestinal system was the most frequently (27.5%) affected system. Over half (86, 52.4%) of the ADRs were mild and 96(58.5%) were preventable. Age group 19 to 59(AOR 0.15[0.03 to 0.35] at 95%CI, p = 0.013), herbal use (AOR 3.07[1.01 to 9.32] at 95%CI, p = 0.048), poly-pharmacy (AOR 8.7[2.4 to 15.77] at 95%CI, p < 0.001) and drug-drug interaction (AOR 6.06[2.79 to 12.5] at 95%CI, p = 0.004) were significantly associated with ADRs among HF patients.

Conclusion

More than half of the hospitalized HF patients experienced at least one ADR during their hospital stay. The use of herbal medicines, poly-pharmacy, and drug-drug interaction were associated with a high risk of ARDs whereas the age group 19 to 59 years was less likely to experience ADRs.

Publication and source details

Original title: Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda

Efrata Ashuro Shegena; Konjit Abebe Nigussie; Robert Tamukong; Boniface Amanee Elias Lumori; Tadele Mekuriya Yadesa

BMC Cardiovascular Disorders · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T21:49:16.307989+00:00

DOI: 10.1186/s12872-022-02937-7 · PMC9650824